Clinical Trials List
2013-05-01 - 2016-06-30
Phase III
Terminated5
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 戴槐青 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 劉冠麟 Division of Urology
- Ya-Chung Tian Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 簡玉樹 Division of Nephrology
- Wen-Chin Lee Division of Nephrology
- 陳德全 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Ju Wu Division of Nephrology
- TUNG-MIN YU Division of Nephrology
- CHENG-HSU CHEN Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 孫樵隱 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
250 participants
